CFDE Data Portal | Search EIF2AK4

	Label	Description
	EIF2AK4 associations Collection (Entity type)	Associations for EIF2AK4_associations
	EIF2AK4 Down Gene Set (Entity type)	A Gene Set from LINCS
	EIF2AK4 Up Gene Set (Entity type)	A Gene Set from LINCS
	EIF2AK4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	EIF2AK4 Gene (Entity type)	ENSG00000128829 - eukaryotic translation initiation factor 2 alpha kinase 4
	GSE150244 TRIM8 knockout 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE186471 1 V 2 CARNOSOL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE208634 1 V 2 DOXYCYCLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

EIF2AK4 associations

Associations for EIF2AK4_associations

EIF2AK4 Down

A Gene Set from LINCS

EIF2AK4 Up

A Gene Set from LINCS

EIF2AK4 associations.tsv

A file from IDG as part of the Harmonizome project

EIF2AK4

ENSG00000128829 - eukaryotic translation initiation factor 2 alpha kinase 4

GSE150244 TRIM8 knockout 3 v 0 human dn

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up

A Gene Set from LINCS

GSE186471 1 V 2 CARNOSOL HUMAN DN

A Gene Set from LINCS

GSE208634 1 V 2 DOXYCYCLINE HUMAN DN

A Gene Set from LINCS

GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.